Prescription Drugs: Describe and discuss the main reasons for the ongoing increases in pharmaceutical expenditures in the United States.
The main reasons for the ongoing increases in pharmaceutical expenditures in the United States include;
A lack of competition primarily because of the U.S. patent system that is there for brand-name drugs
Higher initial costs of developing, marketing, and selling a brand-new drug are also the reason behind the increased price of pharmaceutical in the United States leading to increased expenditure on pharmaceuticals in the USA.
Prescription Drugs: Describe and discuss the main reasons for the ongoing increases in pharmaceutical expenditures in...
Prescription Drugs: Describe and discuss the structure of the pharmaceutical industry.
Prescription Drugs: . Describe and discuss the development of new drugs by the U.S. pharmaceutical industry.
Prescription Drugs: Describe and discuss the rationale for considering the pharmaceutical industry a public policy dilemma.
The US pharmaceutical industry spent $6.4 billion on advertising prescription drugs directly to consumers in 2016. Since 1962 these ads have been regulated by the Food and Drug Administration (FDA) to ensure that they are not false or misleading. The United States and New Zealand are the only two countries where direct-to-consumer (DTC) advertising of prescription drugs is legal. Why should prescription drugs be advertised directly to consumers? Write at least five reasons.
Prescription Drugs: Describe and discuss the consequences of price controls on prescription drugs.
Prescription Drugs: Describe and discuss the political attractiveness of price controls on prescription drugs.
Prescription Drugs: Describe and discuss the history of prescription drug regulation.
Prescription Drugs: Describe and discuss why prescription drugs are expected to be priced lower overseas than US.
Prescription Drugs: Describe and discuss the rationale for FDA regulation of drugs.
Prescription Drugs: Describe and discuss the FDA’s guidelines for safety and efficacy.